Australian Clinical Labs Limited carries a market capitalization of 427.13M, placing it among publicly traded companies globally.
| Market Cap | 427.13M |
| Enterprise Value | N/A |
Australian Clinical Labs Limited's stock has declined approximately -16.42336% over the past 52 weeks. The 50-day moving average sits at 2.05, while the 200-day moving average is 2.37.
| Beta (5Y) | N/A |
| 52-Week Price Change | -16.42336% |
| 50-Day Moving Average | 2.05 |
| 200-Day Moving Average | 2.37 |
| Average Volume (20 Days) | N/A |